Key Metrics
Eigenfactor 

< 0.001
Impact Factor 

< 5
Recommended pre-submission checks
Powered by 

Topics Covered on JOURNAL OF HEPATOCELLULAR CARCINOMA
JOURNAL OF HEPATOCELLULAR CARCINOMA Journal Specifications
Indexed in the following public directories
Web of Science
DOAJ
SJR
| Overview | |
| Publisher | DOVE MEDICAL PRESS LTD |
| Language | English |
| Frequency | Continuous publication |
| Article Processing Charges | USD 2836 |
| Publication Time | 16 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Continuous publication |
| Publication Start Year | 2014 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY, CC BY-NC |
| OA statement | Visit website |
View less
Planning to publish in JOURNAL OF HEPATOCELLULAR CARCINOMA ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in JOURNAL OF HEPATOCELLULAR CARCINOMA
PTM-Related Signatures Predict Lymph Node Metastasis and Shape Microenvironment in Hepatocellular Carcinoma: A Single-Cell and Bulk Integrated Analysis
- 29 Jul 2026
- Journal of Hepatocellular Carcinoma
Giant Atypical Hepatocellular Adenoma of Unknown Etiology in a Young Male: A Case Report
- 27 Jul 2026
- Journal of Hepatocellular Carcinoma
Metabolic Reprogramming-Targeted Therapeutic Strategies in Primary Liver Cancer: A Bibliometric and Visualized Analysis
- 22 Jul 2026
- Journal of Hepatocellular Carcinoma
Prognostic Significance of Combined \u03b1-Fetoprotein and PIVKA-II for Hepatocellular Carcinoma After Hepatectomy
- 22 Jul 2026
- Journal of Hepatocellular Carcinoma
Stage-Dependent Efficacy of TACE Combined with Tyrosine Kinase and Immune Checkpoint Inhibitors as Conversion Therapy for Unresectable Hepatocellular Carcinoma: A Multicenter Retrospective Study
- 17 Jul 2026
- Journal of Hepatocellular Carcinoma
Adjuvant Sintilimab Plus Bevacizumab After Curative Resection of Spontaneously Ruptured Hepatocellular Carcinoma: Protocol for a Prospective, Exploratory, Single-Arm Study (CLEAR-2)
- 16 Jul 2026
- Journal of Hepatocellular Carcinoma
PTM-Related Signatures Predict Lymph Node Metastasis and Shape Microenvironment in Hepatocellular Carcinoma: A Single-Cell and Bulk Integrated Analysis
- 29 Jul 2026
- Journal of Hepatocellular Carcinoma
Giant Atypical Hepatocellular Adenoma of Unknown Etiology in a Young Male: A Case Report
- 27 Jul 2026
- Journal of Hepatocellular Carcinoma
Metabolic Reprogramming-Targeted Therapeutic Strategies in Primary Liver Cancer: A Bibliometric and Visualized Analysis
- 22 Jul 2026
- Journal of Hepatocellular Carcinoma
Prognostic Significance of Combined \u03b1-Fetoprotein and PIVKA-II for Hepatocellular Carcinoma After Hepatectomy
- 22 Jul 2026
- Journal of Hepatocellular Carcinoma
Stage-Dependent Efficacy of TACE Combined with Tyrosine Kinase and Immune Checkpoint Inhibitors as Conversion Therapy for Unresectable Hepatocellular Carcinoma: A Multicenter Retrospective Study
- 17 Jul 2026
- Journal of Hepatocellular Carcinoma
Adjuvant Sintilimab Plus Bevacizumab After Curative Resection of Spontaneously Ruptured Hepatocellular Carcinoma: Protocol for a Prospective, Exploratory, Single-Arm Study (CLEAR-2)
- 16 Jul 2026
- Journal of Hepatocellular Carcinoma